Article Details

Zacks Investment Research Upgrades Viking Therapeutics (NASDAQ:VKTX) to "Hold"

Retrieved on: 2021-02-23 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Upgrades Viking Therapeutics (NASDAQ:VKTX) to "Hold". View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-vktx-a-buy-or-sell-right-now-2021-02/

Excerpt

BlackRock Inc. now owns 5,316,337 shares of the biotechnology company's stock valued at $29,931,000 after purchasing an additional 605,585 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up